Deep01 is the first AI company in Asia to obtain
US and Taiwan FDA clearances
Our mission is to improve medical quality by providing AI solutions
Midline shift detection and measurement
ICH detection, localization, and notification
AI-powered emergency stroke and head trauma network
Co-Founder & COO
Founder & CEO
David received his MS from Carnegie Mellon University CS and BS from National Taiwan University EE. He was a research fellow at Harvard University. He has multi-industry work experience, including software engineer, sales manager, VC, and startup. More: www.linkedin.com/in/deep01/.
Jesse Wang, MD
Jesse received his MD from National Taiwan University. He is an attending neurosurgeon at National Taiwan University Hospital with more than 10 years experience. He finished residency training at National Taiwan University Hospital. He is also a PhD candidate at National Chiao Tung University.
US Plug & Play is an investor in Deep01.
Deep01 won the 2nd place out of 900+ teams in a Beijing, China Startup Contest. Deep01 also won the 1st place in the semi-final competition in Taiwan.
Deep01 was top-picked as the TIEC team for Silicon Valley Plan and TechCrunch SF.
Deep01 won the 2nd place in the Dark Horse Contest, the most famous startup contest in China. Deep01 also won the 1st place in the semi-final in Taiwan.
Taiwan Capital TEN (Tsing Hua Entrepreneur Network) is an investor in Deep01.
Deep01 was top-picked as a Harvard MGH fellow with a full scholarship by the Leap Program.
Deep01 was the first AI startup in the Asia-Pacific region to obtain FDA clearance.
Deep01 won the Taiwan Innovation award.
Deep01 was awarded as 2020 Taiwan Top 10 Startups by the Minister of Science and Technology.